Dimension scores by disease characteristics. Values are given as mean (SD) or as median (IQR)
Sex | Rheumatoid factor | Disease duration | |||||
---|---|---|---|---|---|---|---|
Possible range | Male | Female | Positive | Negative | ≤2 Years | >2 Years | |
*p<0.05; **p<0.001; ***p<0.0001. | |||||||
For abbreviations see table 2. | |||||||
Impairment | |||||||
SF-36 BP | 0–100 | 48 (24) | 44 (24) | 44 (24) | 48 (24)* | 44 (22) | 46 (25) |
DAS28 | 0–10 | 3.9 (1.7) | 4.3 (1.5)*** | 4.3 (1.5) | 3.8 (1.6)** | 4.2 (1.6) | 4.2 (1.6) |
RADAI | 0–10 | 2.9 (1.6–3.6) | 3.3 (1.8–5.1) | 3.4 (1.9–5.0) | 2.9 (1.6–4.5)* | 3.3 (2.0–5.1) | 3.1 (1.7–4.9) |
x Ray score | 0–160 | 4 (0–21) | 6 (1–24) | 7 (1–26) | 3 (0–14)*** | 0 (0–5) | 9 (2–32)*** |
Activity limitation | |||||||
HAQ | 0–3 | 0.8 (0.1–1.5) | 1.1 (0.5–1.8)*** | 1.1 (0.5–1.8) | 0.8 (0.1–1.5)** | 0.9 (0.3–1.4) | 1.1 (0.5–1.8)*** |
SF-36 PF | 0–100 | 63 (40–85) | 55 (30–80)** | 55 (30–80) | 65 (40–83)* | 66 (40–85) | 55 (30–80)** |
Participation restriction | |||||||
SF-36 SF | 0–100 | 88 (63–100) | 75 (63–100) | 75 (50–100) | 88 (63–100) | 75 (63–75) | 88 (56–100) |
SF-36 RE | 0–100 | 100 (33–100) | 100 (33–100) | 100 (33–100) | 100 (33–100) | 100 (0–100) | 100 (33–100) |
SF-36 RP | 0–100 | 50 (0–100) | 25 (0–100)* | 25 (0–100) | 50 (0–100) | 25 (0–75) | 25 (0–100) |